Drugs / 91-day Levonorgestrel Oral Contraceptive
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00781456 | Jan 2009 → Aug 2011 | migraine disorder | Duramed Research | Completed | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 91-day Levonorgestrel Oral Contraceptive | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00781456 ↗ |
| Route | Oral | “91-day extended cycle oral contraceptive” NCT00781456 ↗ |